Tempus ECG-Low EF vs TeraRecon Aorta.CT
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is designed for early identification of low left ventricular ejection fraction using ECGs to aid in heart failure risk assessment. Tool B, conversely, focuses on detailed anatomical segmentation of the aorta from CT angiography for procedure planning and patient management. While both are cardiology AI tools, they serve distinct diagnostic and planning purposes with different input modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Tempus ECG-Low EF is designed to analyze 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. TeraRecon Aorta.CT, on the other hand, automatically segments and labels anatomical landmarks of the Aorta from CT Angiography scans to aid in patient management and procedure planning.
Tempus ECG-Low EF requires resting, non-ambulatory 12-lead ECG recordings. TeraRecon Aorta.CT processes CT Angiography with contrast DICOM images.
Tempus ECG-Low EF provides a binary output indicating 'Low LVEF Detected' or 'Not Detected' to aid clinicians in further evaluation. TeraRecon Aorta.CT outputs DICOM result files that include automatic 3D segmentation of the Aorta and labeling of its anatomical landmarks, which can be used by other DICOM-compliant systems.
Tempus ECG-Low EF is intended for use in Cardiology, Emergency Medicine, and Internal Medicine. TeraRecon Aorta.CT is designed to support Cardiology, Radiology, and Vascular Surgery specialties.
Neither tool provides a definitive diagnosis. Tempus ECG-Low EF detects signs associated with low LVEF and aids clinicians in further evaluation, but it is not a standalone diagnostic tool. TeraRecon Aorta.CT explicitly states that it does not alter original input data or provide a diagnosis.
Tempus ECG-Low EF is intended for use in patients 40 years or older at risk of heart failure. TeraRecon Aorta.CT is indicated for generating results from aortic CT Angiography scans taken of adult patients, with exceptions for those with pre-existing aortic devices, bicuspid aortic valve anomaly, aortic dissection, aortic rupture, and abdominal metallic devices.
More Comparisons
Backers
Who funded each tool's parent company.